Oscar Health Inc (NYSE:OSCR) -12.68% Down Over A Week, Can The Stock Hit Well Above -$2.06?

In last trading session, Oscar Health Inc (NYSE:OSCR) saw 5.17 million shares changing hands with its beta currently measuring 1.67. Company’s recent per share price level of $14.19 trading at -$0.46 or -3.14% at ring of the bell on the day assigns it a market valuation of $3.56B. That closing price of OSCR’s stock is at a discount of -67.65% from its 52-week high price of $23.79 and is indicating a premium of 12.4% from its 52-week low price of $12.43. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.78 million shares which gives us an average trading volume of 4.56 million if we extend that period to 3-months.

For Oscar Health Inc (OSCR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.38. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.85 in the current quarter.

Oscar Health Inc (NYSE:OSCR) trade information

Upright in the red during last session for losing -3.14%, in the last five days OSCR remained trading in the red while hitting it’s week-highest on Friday, 03/07/25 when the stock touched $14.19 price level, adding 14.31% to its value on the day. Oscar Health Inc’s shares saw a change of 5.58% in year-to-date performance and have moved -12.68% in past 5-day. Oscar Health Inc (NYSE:OSCR) showed a performance of -3.60% in past 30-days. Number of shares sold short was 22.31 million shares which calculate 3.99 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 21 to the stock, which implies a rise of 32.43% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 28. It follows that stock’s current price would jump 64.76% in reaching the projected high whereas dropping to the targeted low would mean a gain of 64.76% for stock’s current value.

Oscar Health Inc (OSCR) estimates and forecasts

This year revenue growth is estimated to rise 21.41% from the last financial year’s standing.

6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 2.86B for the same. And 6 analysts are in estimates of company making revenue of 2.76B in the next quarter. Company posted 2.14B and 2.22B of sales in current and next quarters respectively a year earlier.

In 2025, company’s earnings growth rate is likely to be around 647.59% while estimates for its earnings growth in next 5 years are of 160.28%.

Oscar Health Inc (NYSE:OSCR)’s Major holders

Insiders are in possession of 3.12% of company’s total shares while institution are holding 92.15 percent of that, with stock having share float percentage of 95.11%. Investors also watch the number of corporate investors in a company very closely, which is 92.15% institutions for Oscar Health Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at OSCR for having 17.38 million shares of worth $275.03 million. And as of 2024-06-30, it was holding 7.5114 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 14.18 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.1246 of outstanding shares, having a total worth of $224.25 million.

On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 6.14 shares of worth $87.1 million or 2.85% of the total outstanding shares. The later fund manager was in possession of 5.41 shares on Dec 31, 2024 , making its stake of worth around $76.81 million in the company or a holder of 2.52% of company’s stock.